Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muscara: Adalimumab in Rheumatoid Arthritis
NCT01609205Phase 4Completed
- Sponsor
- Hamed Rezaei
- Start
- Oct 2012
- Primary completion
- Sep 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Hamed Rezaei. Started Oct 2012; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01609205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609205.